Globeflex Capital’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$144K Buy
+3,552
New +$152K 0.02% 339
2023
Q1
– Sell
-14,279
Closed -$127K – 510
2022
Q4
$127K Buy
+14,279
New +$135K 0.02% 374

Other funds holding URGN

Globeflex Capital's URGN Position: Q3 2026 in Review

Globeflex Capital opened a new position in UroGen Pharma (URGN) in Q3 2026: 3,552 shares worth $144K. The stake represents 0.02% of the portfolio and ranks #339 among its holdings. This is a return to the name: Globeflex Capital previously reported a position in URGN as recently as Q4 2022.

Globeflex Capital first reported a position in URGN in Q4 2022 and has held it in 2 quarters since. 221 funds tracked by Wall St. Rank hold URGN as of Q3 2026.

  • Globeflex Capital held 3,552 shares of UroGen Pharma worth $144K as of Q3 2026.
  • UroGen Pharma was a new Globeflex Capital position in Q3 2026.
  • UroGen Pharma made up 0.02% of Globeflex Capital's portfolio in Q3 2026, its #339 holding.
  • Globeflex Capital first reported a position in UroGen Pharma in Q4 2022 and has held it in 2 quarters since.
  • 221 funds tracked by Wall St. Rank held UroGen Pharma as of Q3 2026.

Based on Globeflex Capital's 13F filing for Q3 2026, filed 16 Nov 2026.